Cost-utility analysis of HMG-CoA reductase inhibitors (Statins) for primary prevention on cardiovascular diseases

Suggested Citation

Yupin Tamteeranon Cost-utility analysis of HMG-CoA reductase inhibitors (Statins) for primary prevention on cardiovascular diseases. Thesis (M.Sc. (Pharmacy Administration))--Mahidol University, 2008. Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/96422

Availability